Amkor rose 1.81% on 29 September, outperforming Apple, Microsoft and Nvidia as US stock indexes edged lower.
Capital markets news reporting across technology, energy, healthcare, and global macro sectors.
Amkor rose 1.81% on 29 September, outperforming Apple, Microsoft and Nvidia as US stock indexes edged lower.
You’re listening to Spotrate Companies in Focus Avai Bio Inc. Symbol: NASDAQ:AVAI Powered by the Spotrate Terminal — delivering coverage of the global security markets.
You’re listening to Spotrate Companies in Focus Quantum Secure Encryption Corp. Symbol: CSE:QSE Powered by the Spotrate Terminal — delivering coverage of the global security markets.
You’re listening to Spotrate Companies in Focus GT Bipharma Symbol: NASDAQ:GTBP Powered by the Spotrate Terminal — delivering coverage of the global security markets.
You’re listening to Spotrate Companies in Focus GoldHaven Resources Symbol: CSE:GOH Powered by the Spotrate Terminal — delivering coverage of the global security markets.
You’re listening to Spotrate Companies in Focus Avai Bio Inc. Symbol: NASDAQ:AVAI Powered by the Spotrate Terminal — delivering coverage of the global security markets.
You’re listening to Spotrate Companies in Focus Aleen Inc. Symbol: CSE-ALEN-U Powered by the Spotrate Terminal — delivering coverage of the global security markets.
You’re listening to Spotrate Market Briefings. Powered by the Spotrate Terminal — delivering real-time coverage across aerospace, defense, and global security markets. From defense contractors and next-generation aviation to space technologies and geopolitical...
You’re listening to Spotrate Market Briefings. Powered by the Spotrate Terminal — delivering real-time coverage across metals, mining, and global resource markets. From gold and critical minerals to exploration-stage companies and development assets, we provide...
You’re listening to Spotrate Market Briefings. Powered by the Spotrate Terminal — delivering real-time coverage across biotechnology, healthcare innovation, and global life sciences markets. From clinical trials and drug development to regulatory milestones and...